Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country

Medulloblastoma is composed of four clinically and prognostically distinct molecular subgroups (WNT, SHH, group 3, and group 4). However, the clinical implications of these subgroups in the context of the unique challenges of low- to middle-income countries are rarely reported. METHODS: We assembled...

Descripción completa

Detalles Bibliográficos
Autores principales: Amayiri, Nisreen, Swaidan, Maisa, Ibrahimi, Ahmed, Hirmas, Nader, Musharbash, Awni, Bouffet, Eric, Al-Hussaini, Maysa, Ramaswamy, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492378/
https://www.ncbi.nlm.nih.gov/pubmed/34609903
http://dx.doi.org/10.1200/GO.21.00127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492378/
https://www.ncbi.nlm.nih.gov/pubmed/34609903
http://dx.doi.org/10.1200/GO.21.00127

Ejemplares similares